These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1612490)

  • 21. Does computed tomography improve patients selection for extracorporeal shock wave lithotripsy (ESWL) of radiolucent gallbladder stones?
    Franke F; Sackmann M; Holl J; Pauletzki J; Neubrand M; Paumgartner G; Sauerbruch T
    Z Gastroenterol; 1992 Mar; 30(3):180-2. PubMed ID: 1590013
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dissolution of gall stones with an ursodeoxycholic acid menthol preparation: a controlled prospective double blind trial.
    Leuschner M; Leuschner U; Lazarovici D; Kurtz W; Hellstern A
    Gut; 1988 Apr; 29(4):428-32. PubMed ID: 3286383
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Final outcome of ursodeoxycholic acid treatment in 126 patients with radiolucent gallstones.
    Gleeson D; Ruppin DC; Saunders A; Murphy GM; Dowling RH
    Q J Med; 1990 Jul; 76(279):711-29. PubMed ID: 2217675
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Multicenter study on the litholytic effect of ursodeoxycholic acid. 30 cases].
    Voirol M; Stalder GA; Fasel J; Séchaud R; Desbaillets LG; Kapp F; Krieg P; Aenishänslin HW; Wyss G
    Schweiz Med Wochenschr; 1983 Apr; 113(17):643-5. PubMed ID: 6346484
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Efficacy of ursodeoxycholic acid in gallbladder cholesterosis accompanied by cholecystolithiasis].
    Il'chenko AA; Orlova IuN
    Eksp Klin Gastroenterol; 2003; (1):46-50, 182. PubMed ID: 12664784
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Innovations in the diagnosis and treatment of cholelithiasis].
    Ivanchenkova RA; Egorov AV; Leonovich AE; At'kova ER
    Eksp Klin Gastroenterol; 2012; (4):66-73. PubMed ID: 23402157
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nucleation time of gall bladder bile in gall stone patients: influence of bile acid treatment.
    Sahlin S; Ahlberg J; Angelin B; Reihnér E; Einarsson K
    Gut; 1991 Dec; 32(12):1554-7. PubMed ID: 1773966
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gallbladder function during gallstone dissolution. Effect of bile acid therapy in patients with gallstones.
    Sylwestrowicz TA; Shaffer EA
    Gastroenterology; 1988 Sep; 95(3):740-8. PubMed ID: 3396819
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Percutaneous cholecystolithotomy: is gall stone recurrence inevitable?
    Donald JJ; Cheslyn-Curtis S; Gillams AR; Russell RC; Lees WR
    Gut; 1994 May; 35(5):692-5. PubMed ID: 8200568
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative efficacy and side effects of ursodeoxycholic and chenodeoxycholic acids in dissolving gallstones. A double-blind controlled study.
    Fromm H; Roat JW; Gonzalez V; Sarva RP; Farivar S
    Gastroenterology; 1983 Dec; 85(6):1257-64. PubMed ID: 6354826
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors affecting gall-stone dissolution rate during chenic acid therapy.
    Maudgal DP; Kupfer RM; Northfield TC
    Gut; 1983 Jan; 24(1):7-10. PubMed ID: 6848433
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Combined therapy with chenodeoxycholic acid and ursodeoxycholic acid of radiolucent biliary lithiasis].
    Pérez Aguilar F; Breto M; del Val A; Berenguer J
    An Med Interna; 1989 Mar; 6(3):119-24. PubMed ID: 2491184
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitative ultrastructural studies of gall bladder epithelium in gall stone free subjects and patients with gall stones.
    Sahlin S; Ahlberg J; Einarsson K; Henriksson R; Danielsson A
    Gut; 1990 Jan; 31(1):100-5. PubMed ID: 2318423
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early results of combined electrohydraulic shock-wave lithotripsy and oral litholytic therapy of gallbladder stones at the University of Iowa.
    Maher JW; Summers RW; Dean TR; Swift J; Heitshusen D; Quinn G
    Surgery; 1990 Oct; 108(4):648-52; discussion 653-4. PubMed ID: 2218875
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gall-stone dissolution and recurrence: are we being misled?
    Somerville KW; Rose DH; Bell GD; Ellis WR; Knapp DR
    Br Med J (Clin Res Ed); 1982 May; 284(6325):1295-7. PubMed ID: 6803946
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of ursodeoxycholic acid for dissolution of gallstone fragments: comparison with the combination of ursodeoxycholic acid and chenodeoxycholic acid.
    Sackmann M; Pauletzki J; Aydemir U; Holl J; Sauerbruch T; Hasford J; Paumgartner G
    Hepatology; 1991 Dec; 14(6):1136-41. PubMed ID: 1959863
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Computed tomographic analysis of gallstones. An in vitro study.
    Hickman MS; Schwesinger WH; Bova JD; Kurtin WE
    Arch Surg; 1986 Mar; 121(3):289-91. PubMed ID: 3947228
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Computed tomography findings predicting the success of silodosin for medical expulsive therapy of ureteral stones.
    Celik S; Akdeniz F; Yildirim MA; Bozkurt O; Bulut MG; Hacihasanoglu ML; Demir O
    Kaohsiung J Med Sci; 2017 Jun; 33(6):290-294. PubMed ID: 28601233
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recurrence and re-recurrence of gall stones after medical dissolution: a longterm follow up.
    O'Donnell LD; Heaton KW
    Gut; 1988 May; 29(5):655-8. PubMed ID: 3396952
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Does drug-induced litholysis still have a place in treatment of gallstones?].
    Swobodnik W
    Ther Umsch; 1993 Aug; 50(8):564-9. PubMed ID: 8211857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.